title: Generation of genetically stable recombinant rotaviruses containing novel genome rearrangements and heterologous sequences by reverse genetics.
abstract: The rotavirus (RV) genome consists of 11 segments of double-stranded RNA (dsRNA). Typically, each segment contains 5' and 3' untranslated regions (UTRs) that flank an open reading frame (ORF) encoding a single protein. RV variants with segments of atypical size owing to sequence rearrangements have been described. In many cases, the rearrangement originates from a partial head-to-tail sequence duplication that initiates after the stop codon of the ORF, leaving the protein product of the segment unaffected. To probe the limits of the RV genome to accommodate additional genetic sequence, we used reverse genetics to insert duplications (analogous to synthetic rearrangements) and heterologous sequences into the 3' UTR of the segment encoding NSP2 (gene 8). The approach allowed the recovery of recombinant RVs that contained sequence duplications (up to 200 bp) and heterologous sequences, including those for FLAG, the hepatitis C virus E2 epitope, and the internal ribosome entry site of cricket paralysis virus. The recombinant RVs grew to high titer (>10(7) PFU/ml) and remained genetically stable during serial passage. Despite their longer 3' UTRs, rearranged RNAs of recombinant RVs expressed wild-type levels of protein in vivo. Competitive growth experiments indicated that, unlike RV segments with naturally occurring sequence duplications, genetically engineered segments were less efficiently packaged into progeny viruses. Thus, features of naturally occurring rearranged segments, other than their increased length, contribute to their enhanced packaging phenotype. Our results define strategies for developing recombinant RVs as expression vectors, potentially leading to next-generation RV vaccines that induce protection against other infectious agents.
authors.affiliation: Rotavirus Molecular Biology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Aitor
authors.initials: A
authors.lastname: Navarro
authors.forename: Shane D
authors.initials: SD
authors.lastname: Trask
authors.forename: John T
authors.initials: JT
authors.lastname: Patton
mesh_terms: D020413:3' Untranslated Regions; D000818:Animals; D019556:COS Cells; D002460:Cell Line; D002522:Chlorocebus aethiops; D005818:Genetic Engineering; D016679:Genome, Viral; D008253:Macaca mulatta; D008969:Molecular Sequence Data; D012367:RNA, Viral / Q000235:genetics; D011995:Recombination, Genetic; D059386:Reverse Genetics; D012401:Rotavirus / Q000235:genetics*; D017422:Sequence Analysis, DNA
chemical_list: D020413:3' Untranslated Regions; D012367:RNA, Viral
references.citation: Virology. 1985 May;143(1):88-103
references.pmid: 2998015
references.citation: Gene Ther. 2008 Dec;15(24):1567-78
references.pmid: 18650851
references.citation: Nat Struct Biol. 1997 Feb;4(2):118-21
references.pmid: 9033591
references.citation: J Gen Virol. 1992 Mar;73 ( Pt 3):633-8
references.pmid: 1312123
references.citation: J Gen Virol. 2012 Jul;93(Pt 7):1483-1494
references.pmid: 22442114
references.citation: J Virol. 2012 Sep;86(17):9015-24
references.pmid: 22674991
references.citation: Virus Res. 2000 Apr;67(2):163-71
references.pmid: 10867195
references.citation: Lancet Infect Dis. 2012 Feb;12(2):136-41
references.pmid: 22030330
references.citation: J Virol Methods. 2012 Feb;179(2):342-50
references.pmid: 22155580
references.citation: J Virol. 2011 Mar;85(5):1970-9
references.pmid: 21177809
references.citation: Curr Opin Struct Biol. 2009 Jun;19(3):267-76
references.pmid: 19362464
references.citation: Nucleic Acids Res. 1988 Jul 11;16(13):6244
references.pmid: 2840642
references.citation: Virology. 2001 Apr 10;282(2):221-9
references.pmid: 11289804
references.citation: J Virol. 2001 Mar;75(5):2076-86
references.pmid: 11160712
references.citation: Structure. 2008 Nov 12;16(11):1678-88
references.pmid: 19000820
references.citation: J Gen Virol. 2012 Jul;93(Pt 7):1385-1409
references.pmid: 22535777
references.citation: J Gen Virol. 1989 Jun;70 ( Pt 6):1329-36
references.pmid: 2543781
references.citation: Virology. 2011 Nov 25;420(2):164-71
references.pmid: 21968198
references.citation: Curr Protoc Microbiol. 2009 Nov;Chapter 15:Unit 15C.3
references.pmid: 19885940
references.citation: J Biol Chem. 2003 Aug 29;278(35):32673-82
references.pmid: 12788926
references.citation: Virology. 1996 Feb 1;216(1):238-40
references.pmid: 8614995
references.citation: Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7928-33
references.pmid: 12048247
references.citation: EMBO J. 2011 Jan 19;30(2):408-16
references.pmid: 21157433
references.citation: Trends Microbiol. 2011 Mar;19(3):136-44
references.pmid: 21195621
references.citation: J Virol. 2000 Aug;74(15):6885-92
references.pmid: 10888628
references.citation: Nat Struct Mol Biol. 2008 Jan;15(1):103-5
references.pmid: 18066080
references.citation: Methods Mol Med. 2000;34:33-66
references.pmid: 21318854
references.citation: Nucleic Acids Res. 2010 Nov;38(21):7718-35
references.pmid: 20671030
references.citation: J Virol. 1993 Nov;67(11):6625-32
references.pmid: 8411365
references.citation: Virus Res. 2009 Feb;139(2):137-47
references.pmid: 18621089
references.citation: J Virol. 1983 Jul;47(1):125-36
references.pmid: 6306269
references.citation: RNA. 2012 Feb;18(2):241-52
references.pmid: 22190746
references.citation: Front Microbiol. 2012 Jun 01;3:186
references.pmid: 22675320
references.citation: J Virol. 1994 Mar;68(3):1682-8
references.pmid: 7509001
references.citation: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18652-7
references.pmid: 20937889
references.citation: J Virol. 1987 Nov;61(11):3365-72
references.pmid: 2822946
references.citation: Methods. 2013 Feb;59(2):199-206
references.pmid: 22687622
references.citation: Pediatr Infect Dis. 1985 Nov-Dec;4(6):632-7
references.pmid: 3001661
references.citation: Virology. 1996 Oct 15;224(2):446-52
references.pmid: 8874505
references.citation: Nucleic Acids Res. 2003 Jul 1;31(13):3429-31
references.pmid: 12824340
references.citation: J Gen Virol. 1984 Jul;65 ( Pt 7):1141-50
references.pmid: 6086807
references.citation: J Virol. 1996 Jun;70(6):4125-30
references.pmid: 8648754
references.citation: Adv Virus Res. 2007;69:167-201
references.pmid: 17222694
references.citation: Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2451-5
references.pmid: 1848704
references.citation: J Virol. 2001 Aug;75(16):7305-14
references.pmid: 11462002
references.citation: J Virol. 1998 Sep;72(9):7387-96
references.pmid: 9696835
references.citation: J Gen Virol. 1987 Nov;68 ( Pt 11):2961-6
references.pmid: 2824672
references.citation: Virus Res. 1987 Jan;6(4):363-82
references.pmid: 3564676
references.citation: Adv Virus Res. 2000;55:185-229
references.pmid: 11050943
references.citation: PLoS One. 2011;6(5):e20080
references.pmid: 21611152
references.citation: J Virol. 2006 Aug;80(16):7984-94
references.pmid: 16873255
references.citation: J Virol. 1988 Jan;62(1):211-7
references.pmid: 3275433
references.citation: Biochem Biophys Res Commun. 2006 Feb 3;340(1):140-4
references.pmid: 16356473
references.citation: Nat Rev Microbiol. 2012 Jan 23;10(3):165-77
references.pmid: 22266782
references.citation: Adv Virus Res. 1996;46:69-95
references.pmid: 8824698
references.citation: J Virol. 2010 Jul;84(13):6711-9
references.pmid: 20427539
references.citation: Virology. 1999 Nov 10;264(1):167-80
references.pmid: 10544142
references.citation: Cold Spring Harb Protoc. 2012 Feb 01;2012(2):199-204
references.pmid: 22301656
references.citation: J Biol Chem. 2010 Jun 11;285(24):18123-8
references.pmid: 20351108